Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection

PHASE2CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 3, 2017

Study Completion Date

October 3, 2017

Conditions
Neovascular Age-Related Macular Degeneration
Interventions
DRUG

REGN910-3

DRUG

Intravitreal Aflibercept Injection (IAI)

Trial Locations (87)

Unknown

Regeneron Investigational Site, Mobile

Regeneron Investigational Site 1, Phoenix

Regeneron Investigational Site 2, Phoenix

Regeneron Investigational Site 3, Phoenix

Regeneron Investigational Site 1, Tucson

Regeneron Investigational Site 2, Tucson

Regeneron Investigational Site, Arcadia

Regeneron Investigational Site, Bakersfield

Regeneron Investigational Site, Beverly Hills

Regeneron Investigational Site, Encino

Regeneron Investigational Site 1, Los Angeles

Regeneron Investigational Site 2, Los Angeles

Regeneron Investigational Site, Mountain View

Regeneron Investigational Site, Oceanside

Regeneron Investigational Site 1, Palm Desert

Regeneron Investigational Site 2, Palm Desert

Regeneron Investigational Site, Palo Alto

Regeneron Investigational Site, Poway

Regeneron Investigational Site, Redlands

Regeneron Investigational Site, Sacramento

Regeneron Investigational Site, Santa Maria

Regeneron Investigational Site, New London

Regeneron Investigational Site, Altamonte Springs

Regeneron Investigational Site, Fort Lauderdale

Regeneron Investigational Site, Lakeland

Regeneron Investigational Site, Largo

Regeneron Investigational Site, Miami

Regeneron Investigational Site, Naples

Regeneron Investigational Site, Palm Beach

Regeneron Investigational Site, Tallahassee

Regeneron Investigational Site, Winter Haven

Regeneron Investigational Site, Augusta

Regeneron Investigational Site, Decatur

Regeneron Investigational Site, ‘Aiea

Regeneron Investigational Site 1, Chicago

Regeneron Investigational Site 2, Chicago

Regeneron Investigational Site, Lemont

Regeneron Investigational Site, Oak Forest

Regeneron Investigational Site, Oak Park

Regeneron Investigational Site, Urbana

Regeneron Investigational Site, New Albany

Regeneron Investigational Site, Des Moines

Regeneron Investigational Site, Metairie

Regeneron Investigational Site 1, Baltimore

Regeneron Investigational Site 2, Baltimore

Regeneron Investigational Site, Chevy Chase

Regeneron Investigational Site 1, Boston

Regeneron Investigational Site 2, Boston

Regeneron Investigational Site, Jackson

Regeneron Investigational Site, Minneapolis

Regeneron Investigational Site, St Louis

Regeneron Investigational Site, Las Vegas

Regeneron Investigational Site, Portsmouth

Regeneron Investigational Site, Edison

Regeneron Investigational Site, Teaneck

Regeneron Investigational Site, Albuquerque

Regeneron Investigational Site, Albany

Regeneron Investigational Site, Bloomfield

Regeneron Investigational Site, Great Neck

Regeneron Investigational Site, Hauppauge

Regeneron Investigational Site, Rochester

Regeneron Investigational Site, Syracuse

Regeneron Investigational Site, Asheville

Regeneron Investigational Site, Charlotte

Regeneron Investigational Site, Durham

Regeneron Investigational Site, Cleveland

Regeneron Investigational Site, Dublin

Regeneron Investigational Site, Portland

Regeneron Investigational Site, Camp Hill

Regeneron Investigational Site, Huntingdon

Regeneron Investigational Site, Ladson

Regeneron Investigational Site, Rapid City

Regeneron Investigational Site, Germantown

Regeneron Investigational Site, Knoxville

Regeneron Investigational Site, Nashville

Regeneron Investigational Site, Abilene

Regeneron Investigational Site 1, Austin

Regeneron Investigational Site 2, Austin

Regeneron Investigational Site, Dallas

Regeneron Investigational Site 1, Fort Worth

Regeneron Investigational Site 2, Fort Worth

Regeneron Investigational Site, Harlingen

Regeneron Investigational Site, Houston

Regeneron Investigational Site, The Woodlands

Regeneron Investigational Site, Willow Park

Regeneron Investigational Site, Salt Lake City

Regeneron Investigational Site, Madison

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT02713204 - Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection | Biotech Hunter | Biotech Hunter